315 related articles for article (PubMed ID: 31752346)
1. Cellular Attachment and Entry Factors for Chikungunya Virus.
Schnierle BS
Viruses; 2019 Nov; 11(11):. PubMed ID: 31752346
[TBL] [Abstract][Full Text] [Related]
2. Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors.
McAllister N; Liu Y; Silva LM; Lentscher AJ; Chai W; Wu N; Griswold KA; Raghunathan K; Vang L; Alexander J; Warfield KL; Diamond MS; Feizi T; Silva LA; Dermody TS
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999033
[TBL] [Abstract][Full Text] [Related]
3. Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion.
van Duijl-Richter MK; Hoornweg TE; Rodenhuis-Zybert IA; Smit JM
Viruses; 2015 Jul; 7(7):3647-74. PubMed ID: 26198242
[TBL] [Abstract][Full Text] [Related]
4. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
[TBL] [Abstract][Full Text] [Related]
6. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
[TBL] [Abstract][Full Text] [Related]
7. Host Factors and Pathways Involved in the Entry of Mosquito-Borne Alphaviruses.
De Caluwé L; Ariën KK; Bartholomeeusen K
Trends Microbiol; 2021 Jul; 29(7):634-647. PubMed ID: 33208275
[TBL] [Abstract][Full Text] [Related]
8. Colocalization of Chikungunya Virus with Its Receptor MXRA8 during Cell Attachment, Internalization, and Membrane Fusion.
Feng F; Bouma EM; Hu G; Zhu Y; Yu Y; Smit JM; Diamond MS; Zhang R
J Virol; 2023 May; 97(5):e0155722. PubMed ID: 37133449
[TBL] [Abstract][Full Text] [Related]
9. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
Akhrymuk I; Lukash T; Frolov I; Frolova EI
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
[TBL] [Abstract][Full Text] [Related]
10. Chikungunya virus: host pathogen interaction.
Singh SK; Unni SK
Rev Med Virol; 2011 Mar; 21(2):78-88. PubMed ID: 21412934
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a Novel Primary Human Skeletal Myoblast Cellular Model for Chikungunya Virus Infection and Pathogenesis.
Hussain KM; Lee RC; Ng MM; Chu JJ
Sci Rep; 2016 Feb; 6():21406. PubMed ID: 26892458
[TBL] [Abstract][Full Text] [Related]
13. Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.
Langsjoen RM; Auguste AJ; Rossi SL; Roundy CM; Penate HN; Kastis M; Schnizlein MK; Le KC; Haller SL; Chen R; Watowich SJ; Weaver SC
Antiviral Res; 2017 Jul; 143():246-251. PubMed ID: 28461071
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
[TBL] [Abstract][Full Text] [Related]
15. Imaging of viral neuroinvasion in the zebrafish reveals that Sindbis and chikungunya viruses favour different entry routes.
Passoni G; Langevin C; Palha N; Mounce BC; Briolat V; Affaticati P; De Job E; Joly JS; Vignuzzi M; Saleh MC; Herbomel P; Boudinot P; Levraud JP
Dis Model Mech; 2017 Jul; 10(7):847-857. PubMed ID: 28483796
[TBL] [Abstract][Full Text] [Related]
16. Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.
Amdekar S; Parashar D; Alagarasu K
Viral Immunol; 2017 Dec; 30(10):691-702. PubMed ID: 28910194
[TBL] [Abstract][Full Text] [Related]
17. Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.
Acharya D; Paul AM; Anderson JF; Huang F; Bai F
PLoS Negl Trop Dis; 2015; 9(10):e0004139. PubMed ID: 26484530
[TBL] [Abstract][Full Text] [Related]
18. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells.
Hoornweg TE; van Duijl-Richter MKS; Ayala Nuñez NV; Albulescu IC; van Hemert MJ; Smit JM
J Virol; 2016 May; 90(9):4745-4756. PubMed ID: 26912616
[TBL] [Abstract][Full Text] [Related]
20. Human keratinocytes restrict chikungunya virus replication at a post-fusion step.
Bernard E; Hamel R; Neyret A; Ekchariyawat P; Molès JP; Simmons G; Chazal N; Desprès P; Missé D; Briant L
Virology; 2015 Feb; 476():1-10. PubMed ID: 25496825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
